Skip to content
  • Home
  • Discovering Seelos
    • Our Focus
    • Our Seelos Management Team
    • Our Board of Directors
    • Careers
  • Pipeline
    • SLS-002 (intranasal ketamine)
      • Acute Suicidal Ideation and Behavior (ASIB) in Major Depressive Disorder (MDD) and Post-Traumatic Stress Disorder (PTSD) 
    • SLS-003 (sublingual ketamine)
    • SLS-004 (gene therapy)
    • SLS-005 (trehalose)
    • SLS-007 (peptidic inhibitor)
  • Patients and Caregivers
    • STRIDES-SCA
    • HEALEY ALS Platform Trial – Regimen E SLS-005 – Trehalose
    • A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide
  • Investors and Media
    • Overview and Financials
    • Corporate Governance
    • Press Releases
    • SEC Filings
    • Stock Information
  • Home
  • Discovering Seelos
    • Our Focus
    • Our Seelos Management Team
    • Our Board of Directors
    • Careers
  • Pipeline
    • SLS-002 (intranasal ketamine)
      • Acute Suicidal Ideation and Behavior (ASIB) in Major Depressive Disorder (MDD) and Post-Traumatic Stress Disorder (PTSD) 
    • SLS-003 (sublingual ketamine)
    • SLS-004 (gene therapy)
    • SLS-005 (trehalose)
    • SLS-007 (peptidic inhibitor)
  • Patients and Caregivers
    • STRIDES-SCA
    • HEALEY ALS Platform Trial – Regimen E SLS-005 – Trehalose
    • A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide
  • Investors and Media
    • Overview and Financials
    • Corporate Governance
    • Press Releases
    • SEC Filings
    • Stock Information

Tag: Alzheimer’s

March 10, 2022: HEALEY ALS Platform Trial Weekly Q&A Webinar with Warren Wasiewski, MD of Seelos Therapeutics and Shafeeq Ladha, MD, Regimen E Co-Lead, discussing the science behind trehalose (SLS-005) 

March 12, 2022

Latest Posts and Media

  • Webcast from the Jefferies Healthcare Conference on 6/8/2023 at 9:00 AM (ET)
  • Replay of Seelos Therapeutics 12/15 R&D Update Webcast
  • Guggenheim Nantucket Therapeutics Conference from 9/28/2022
  • LifeSci KOL Event: Suicidal Patients in the ED from 4/25/2022
  • March 10, 2022: HEALEY ALS Platform Trial Weekly Q&A Webinar with Warren Wasiewski, MD of Seelos Therapeutics and Shafeeq Ladha, MD, Regimen E Co-Lead, discussing the science behind trehalose (SLS-005) 

Follow Seelos

  • Twitter
  • LinkedIn

Offices
Seelos Therapeutics, Inc.
300 Park Avenue
New York, NY 10022

Incorporated
Nevada

Entity type
Corporation

Identifiers
CIK:1017491
IRS:870449967

© 2023 Seelos Therapeutics, Inc.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT